CA2456322A1 - Compositions and methods to prevent abuse of opioids - Google Patents

Compositions and methods to prevent abuse of opioids Download PDF

Info

Publication number
CA2456322A1
CA2456322A1 CA002456322A CA2456322A CA2456322A1 CA 2456322 A1 CA2456322 A1 CA 2456322A1 CA 002456322 A CA002456322 A CA 002456322A CA 2456322 A CA2456322 A CA 2456322A CA 2456322 A1 CA2456322 A1 CA 2456322A1
Authority
CA
Canada
Prior art keywords
dosage form
opioid
oral dosage
antagonist
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002456322A
Other languages
French (fr)
Inventor
Christopher Breder
Robert Colucci
Benjamin Oshlack
Richard Sackler
Curtis Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro-Celtique, S.A.
Christopher Breder
Robert Colucci
Benjamin Oshlack
Richard Sackler
Curtis Wright
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/310,516 priority Critical
Priority to US31051601P priority
Priority to US31053701P priority
Priority to US31051501P priority
Priority to US60/310,537 priority
Priority to US60/310,515 priority
Application filed by Euro-Celtique, S.A., Christopher Breder, Robert Colucci, Benjamin Oshlack, Richard Sackler, Curtis Wright filed Critical Euro-Celtique, S.A.
Priority to PCT/US2002/024934 priority patent/WO2003013479A1/en
Publication of CA2456322A1 publication Critical patent/CA2456322A1/en
Abandoned legal-status Critical Current

Links